A symptom provocation study in contamination-based obsessive-compulsive disorder using augmented reality

Withdrawn

• Conditions: Anxiety; contamination fear; 10002861

• Registration Number: NL-OMON47525
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

The recruitment of participants takes place as follows. Practitioners at the department of Psychiatry will inform OCD-patients currently being treated or are currently waitlisted for treatment within our institution about our study. If someone is willing to participate in the study, we will personally visit with them at the Psychiatry department to inform them of the entire procedure. Moreover, they will receive an information letter by email that reviews all of the information again in detail in order to ensure that they have the opportunity to fully understand the procedure. If they are still interested in participating, they will sign an informed consent and we will perform screening for inclusion and exclusion criteria. Demographics and clinician-related questionnaires (Y-BOCS, GAF, HAM-D, HAM-A. BABS) will be administered to make sure that the individual can participate. If a participant meets any of the exclusion criteria, then they are excluded from participating in this study.;Inclusion criteria for OCD group:
-Men and women.
-Age between 25-65.
-Recent DSM-V diagnosis (mild, moderate, and severe) of obsessive-compulsive disorder with a primary diagnosis of contamination fear.
-Currently in treatment or are waiting for treatment in the AMC department of Psychiatry

Exclusion Criteria

Exclusion criteria for OCD participants:
- A primary DSM-V diagnosis for any disorder(s) besides contamination-based obsessive-compulsive disorder or other subtype of obsessive-compulsive disorder.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- AR HMD task, the main study parameters consist of self-reports measured by a<br /><br>VAS and physiological recordings of heart rate and Skin Conductance level (SCL)<br /><br>measured by the VU-AMS.<br /><br>- Traditional Symptom Provocation task, the main study parameters consist of<br /><br>self-reports measured by a VAS and physiological recordings of heart rate and<br /><br>Skin Conductance level (SCL) measured by the VU-AMS. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N/A</p><br>